David M Goldstein insider trades: Alumis (ALMS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | ALMS | ↓ Sell | 629 | $6.52 | $4K | Direct | Nov 4, 2026 (2d) |
| Aug 3, 2026 | ALMS | ↓ Sell | 2,596 | $26.37 | $68K | Direct | Aug 5, 2026 (2d) |
| Aug 10, 2020 | PRNB | ↓ Sell | 6,000 | $88.61 | $532K | Direct | Aug 12, 2020 (2d) |
| May 7, 2020 | PRNB | ↓ Sell | 6,000 | $60.16 | $361K | Direct | May 8, 2020 (1d) |
| Feb 10, 2020 | PRNB | ↓ Sell | 6,000 | $70.90 | $425K | Direct | Feb 12, 2020 (2d) |
| Nov 7, 2019 | PRNB | ↓ Sell | 10,000 | $32.39 | $324K | Direct | Nov 8, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ALMS insiders
Open-market trades in the last 12 months
About David M Goldstein's insider trades
David M Goldstein is Chief Scientific Officer at Alumis (ALMS). Since Nov 7, 2019, David has reported no open-market purchases and 6 sales worth $1.7M on SEC Form 4. In the last 12 months: 2 sales ($73K).
Their filings also include grants and awards (6 filings), option exercises (4 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALMS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.